Correction to: Puerarin alleviates burn-related procedural pain mediated by P2X3 receptors.

Due to the authors' carelessness, we used mistakenly PBMCs isolated from same patient in Fig. 1a for P2X3 immunoreactivity in VI: PUE-treated group on the second day (Third row middle graph) and VII: PUE-treated on the third day (Third row right- side graph).